CoChat

The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence

The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.

Abstract

Memantine, a non-competitive NMDA receptor antagonist approved for Alzheimer's disease with a good safety profile, is increasingly being studied in a variety of non-dementia psychiatric disorders. We aimed to critically review relevant literature on the use of the drug in such disorders. We performed a PubMed search of the effects of memantine in animal models of psychiatric disorders and its effects in human studies of specific psychiatric disorders. The bulk of the data relates to the effects of memantine in major depressive disorder and schizophrenia, although more recent studies have provided data on the use of the drug in bipolar disorder as an add-on. Despite interesting preclinical data, results in major depression are not encouraging. Animal studies investigating the possible usefulness of memantine in schizophrenia are controversial; however, interesting findings were obtained in open studies of schizophrenia, but negative placebo-controlled, double-blind studies cast doubt on their validity. The effects of memantine in anxiety disorders have been poorly investigated, but data indicate that the use of the drug in obsessive-compulsive disorder and post-traumatic stress disorder holds promise, while findings relating to generalized anxiety disorder are rather disappointing. Results in eating disorders, catatonia, impulse control disorders (pathological gambling), substance and alcohol abuse/dependence, and attention-deficit hyperactivity disorder are inconclusive. In most psychiatric non-Alzheimer's disease conditions, the clinical data fail to support the usefulness of memantine as monotherapy or add-on treatment However, recent preclinical and clinical findings suggest that add-on memantine may show antimanic and mood-stabilizing effects in treatment-resistant bipolar disorder.

Overview

Integrity signals

Registry

Crossref · 10.2165/11634390-000000000-00000

Cites

238 of 238 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 238 references

Research works printed but not linked: 8

  1. Dingledine, 1999, Pharmacol Rev, 51, 7
  2. Danysz, 1995, Behav Pharmacol, 6, 455
  3. Petrović, 2005, Prague Med Rep, 106, 113
  4. Berger, 2003, Psychopharmacol Bull, 37, 79
  5. Feusner, 2009, Psychopharmacology Bull, 42, 81
  6. Roncero, 2009, Actas Esp Psiquiatr, 37, 205
  7. Grant, 2011, Erratum in: Br J Psychiatry, 198, 75
  8. Parsons, 2005, Handb Exp Pharmacol, &NA;, 249

Cited by

See all 283

Metadata

Authors
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., Simonetti, A., Demontis, F., Serra, G., & Girardi, P.
Affiliations
  • Azienda Ospedaliera Sant'Andrea (IT)
  • University of Sassari (IT)
Corresponding author
Sani, Gabriele
Venue
CNS Drugs
Published
2012-08
Volume
26
Issue
8
Pages
663-690
ISSN
1172-7047 (ISSN-L)
OpenAlex
W1524631360
Cited by
273
References
238
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 8 · 2021: 6 · 2020: 160 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 17 · 2014: 19 · 2013: 14
FWCI
1.85
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
memantine, NMDA receptor antagonists, major depressive disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder, post-traumatic stress disorder, generalized anxiety disorder, eating disorders, catatonia, impulse control disorders, substance use disorders, alcoholism, attention deficit hyperactivity disorder, adjunctive therapy, treatment-resistant bipolar disorder, mood stabilization
MeSH terms
Animals, Mental Disorders, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Memantine, Treatment Outcome, Excitatory Amino Acid Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence. https://app.cochat.ai/papers/10.2165/11634390-000000000-00000
The paper
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., Simonetti, A., Demontis, F., Serra, G., & Girardi, P. (2012). The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence. CNS Drugs. https://doi.org/10.2165/11634390-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.